-
Synthetic Biology & Advanced Compound Production3 weeks ago
HDX-MS Plus Computational Methods Provide Novel Approach to Study of Protein-Protein Interactions
HDX-MS Plus Computational Methods Provide Novel Approach to Study of Protein-Protein Interactions
-
Synthetic Biology & Advanced Compound Production3 weeks ago
Benchtop Bioreactor Simplifies Macrophage Manufacturing
Benchtop Bioreactor Simplifies Macrophage Manufacturing
-
Synthetic Biology & Advanced Compound Production3 weeks ago
CAR T Production Bottlenecks Best Tackled with AI, Automation, and Skilled Staff
CAR T Production Bottlenecks Best Tackled with AI, Automation, and Skilled Staff
-
Uncategorized3 weeks agoRead the latest issue of DDW
The new issue of DDW is now on its way to subscribers and available to read online. The Spring issue explores the next phase of obesity medications...
-
BioPharma Dive – AI / Data3 weeks agoAspen’s fresh Parkinson’s data; Aldeyra tanks following FDA rejection
Aspen Neuroscience presented positive Phase 1/2 data for its stem cell-derived therapy. Elsewhere, Aldeyra lost over half its market value following a rejection from the FDA.
-
BioPharma Dive – AI / Data3 weeks agoCrossbow raises $77M for new cancer immunotherapies
Backed by more than a dozen investors, the biotech startup will use the funding to further a Phase 1 trial of its lead program CBX-250.
-
Fierce Biotech3 weeks ago
Avoiding 11th hour surprises in clinical trials
Proactive coordination is essential to protect patients, sponsors and trial integrity, especially as teams navigate the new UK Clinical Trial Regulation. Hear why alignment matters more...
-
ScienceDaily – Biotechnology3 weeks ago
Scientists just discovered bull sharks have friends
Bull sharks may have a reputation as lone hunters, but new research reveals they actually form social bonds and even have preferred “friends.” After six years...
-
Nature Biotechnology3 weeks ago
An engineered E. coli strain sustains intratumoral nitric oxide production to boost effectiveness of tumor immunotherapy
Nature Biotechnology, Published online: 18 March 2026; doi:10.1038/s41587-026-03055-x An engineered Escherichia coli Nissle 1917 strain carrying a synthetic arginine–nitric oxide (NO) circuit enables sustained intratumoral NO...
-
Nature Biotechnology3 weeks ago
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy
Nature Biotechnology, Published online: 18 March 2026; doi:10.1038/s41587-026-03054-y Solid tumors are sensitized to anti‑PD‑L1 immunotherapy by engineered E. coli to produce nitric oxide.
BioNTech to shutter Singapore HQ after ‘comprehensive review’
STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say
